Association of malnutrition-inflammation-cardiovascular disease with cognitive deterioration in peritoneal dialysis patients

  • Li-ping DUAN ,
  • Zhao-xia ZHENG ,
  • Yu-hui ZHANG ,
  • Jie DONG
Expand
  • 1. Handan Central Hospital, Department 1 of Nephrology, Handan 056001, Hebei, China
    2. Renal Division, Department of Medicine; Institute of Nephrology, Peking University First Hospital; Key Laboratory of Renal Disease, Ministry of Health of China; Key Laboratory of Chronic Kidney Disease Prevention and Treatment, Ministry of Education, Beijing 100034, China

Received date: 2019-03-18

  Online published: 2019-06-26

Supported by

Supported by the NEW Century Excellent Talents from Education Department of China, the Baxer Clinical Research Award from Baxer Corp of China,and International Society of Nephrology Research Award from the Global Outreach Research and Prevention Committee

Abstract

Objective: To investigate the relationship between malnutrition-inflammation-atherosclerosis (MIA) syndrome and deterioration of global and specific domains of cognitive function in peritoneal dialysis (PD) patients.Methods: This was a multi-center prospective cohort study. The PD patients who met the inclusion criteria were examined with general and specific cognitive function between March 2013 and November 2013. The patients were divided into MIA0, MIA1 and MIA2 groups, according to items of “Yes” for whether or not having cardiovascular disease, serum albumin≤35 g/L or high-sensitive C-reactive protein (hs-CRP) ≥3 mg/L. After 2 years, the patients maintained on PD would be repeatedly measured with cognitive function. The Chi-square test, One-way ANOVA, Kruskal-wallis H rank sum test were used to compare the differences of clinical characteristics, biochemical data, and global and specific cognitive function parameters among the three groups at baseline, and two years later, respectively. The Bonferroni method was applied to adjust the significance level for further comparison between each two different groups. The change of score in each cognitive parameter of global and specific domains was used as dependent variable. Age, gender, education level, depression index, body-mass index, diabetes mellitus, serum sodium levels and MIA (MIA0 was control, MIA1 and MIA2 as dummy variables) were all included in the multivariable linear regression models to analyze the risk factors of the deterioration of cognitive function. The analysis for each cognitive domain was adjusted for the baseline score of the corresponding cognitive parameter. All the analyses were performed using SPSS for Windows, software version 25.0 (SPSS Inc., Chicago, IL). Results: Over two-year follow up, the prevalence of cognitive impairment increased from 20.0% to 24.7%, absolute decrease of 3MS scores were more significantly decreased in MIA2 (-3.9±12.0 vs. 1.1±6.7, P<0.01) and MIA1 group (-2.3±11.8 vs. 1.1±6.7, P<0.05) than those in MIA0 group respectively. Specific cognitive functions, included executive function (trail-making tests A and B, P=0.401,P=0.176), immediate memory (P=0.437), delayed memory (P=0.104), visuospatial skill (P=0.496), and language ability (P=0.171) remained unchanged. Advanced age, lower education, diabetes mellitus and depression were all correlated with the deterioration of one or more cognitive domains, and the patients having one item of MIA syndrome were prone to develop the deterioration of 3MS (P=0.022). Furthermore, the patients having two or more items of MIA syndrome were more likely to develop the deterioration of not only 3MS (P <0.001), but also delayed memory, visuospatial skill, and language ability (P=0.002, P=0.007, P=0.004, respectively).Conclusion: Patients with one item or above of MIA syndrome were at high-risk for the deterioration of global cognitive function. The more MIA syndrome items there were, the more specific cognitive domains deteriorated.

Cite this article

Li-ping DUAN , Zhao-xia ZHENG , Yu-hui ZHANG , Jie DONG . Association of malnutrition-inflammation-cardiovascular disease with cognitive deterioration in peritoneal dialysis patients[J]. Journal of Peking University(Health Sciences), 2019 , 51(3) : 510 -518 . DOI: 10.19723/j.issn.1671-167X.2019.03.020

References

[1] Griva K, Stygall J, Hankins M , et al. Cognitive impairment and 7-year mortality in dialysis patients[J]. Am J Kidney Dis, 2010,56(4):693-703.
[2] Shea YF, Lam MF, Lee MS , et al. Prevalence of cognitive impairement among peritoneal dialysis patients, impact on peritonitis and role of assisted dialysis[J]. Perit Dial Int, 2016,36(3):284-290.
[3] Kalirao P, Pederson S, Foley RN , et al. Cognitive impairment in peritoneal dialysis patients[J]. Am J Kidney Dis, 2011,57(4):612-620.
[4] Kurella M, Chertow GM, Luan J , et al. Cognitive impairment in chronic kidney disease[J]. J Am Geriatr Soc, 2004,52(11):1863-1869.
[5] Dong J, Pi HC , Xiong ZY, et a1. Depression and cognitive impairment in peritoneal dialysis: A multi-center cross-sectional study[J]. Am J Kidney Dis, 2016,67(1):111-118.
[6] Zhang YH, Yang ZK, Wang JW , et al. Cognitive changes in peritoneal dialysis patients: a multi-center prospective cohort study[J]. Am J Kidney Dis, 2018,72(5):691-700.
[7] Kurella M, Mapes DL , Port FK, et a1. Correlates and outcomes of dementia among dialysis patients: the dialysis outcomes and practice patterns study[J]. Nephrol Dial Transplant, 2006,21(9):2543-2548.
[8] Weiner DE, Scott TM , Giang LM, et a1. Cardiovascular disease and cognitive function in maintenance hemodialysis patients[J]. Am J Kidney Dis, 2011,58(5):773-781.
[9] Roberts RO, Geda YE , Knopman DS, et a1. Association of C-reactive protein with mild cognitive impairment[J]. Alzheimers Dement, 2009,5(5):398-405.
[10] Radi c ' J , Ljutic D , Radi c ' M , et al. Cognitive-psychomotor functions and nutritional status in maintenance hemodialysis patients: are they related[J]. Ther Apher Dial, 2011,15(6):532-539.
[11] Tamura MK, Yaffe K . Dementia and cognitive impairment in ESRD: diagnostic and therapeutic strategies[J]. Kidney Int, 2011,79(1):14-22.
[12] Etgen T, Chonchol M, F?rstl H , et al. Chronic kidney disease and cognitive impairment: a systematic review and meta-analysis[J]. Am J Nephrol, 2012,35(5):474-482.
[13] 段丽萍, 郑朝霞, 吕宁 , 等. 腹膜透析患者营养不良-炎症-心血管疾病和认知功能的关系[J]. 中国血液净化, 2016,15(11):600-604.
[14] Smith SC, Jackson R, Pearson TA , et al. Principles for national and regional guidelines on cardiovascular disease prevention: a scientific statement from the World Heart and Stroke Forum[J]. Circulation, 2004,109(25):3112-3121.
[15] Teng EL, Chui HC . The modified mini-mental state (3MS) examination[J]. J Clin Psychiatry, 1987,48(8):314-318.
[16] Kurella M, Chertow GM, Fried LF , et al. Chronic kidney disease and cognitive impairment in the elderly: the health, aging, and body composition study[J]. J Am Soc Nephrol, 2005,16(7):2127-2133.
[17] Lin FR, Yaffe K, Xia J , et al. Hearing loss and cognitive decline in older adults[J]. JAMA Intern Med, 2013,173(4):293-299.
[18] Randolph C . Repeatable battery for the assessment of neuropsychological status (RBANS)[Z]. San Antonio, TX: The Psychological Corporation, 1998.
[19] Cheng Y, Wu W, Wang J , et al. Reliability and validity of the repeatable battery for the assessment of neuropsychological status in community-dwelling elderly[J]. Arch Med Sci, 2011,7(5):850-857.
[20] 张保华, 谭云龙, 张五芳 , 等. 重复性成套神经心理状态测验的信度、效度分析[J]. 中国心理卫生杂志, 2008,22(12):865-869.
[21] 杨贵刚, 田菊, 谭云龙 , 等. 重复性成套神经心理状态测验在北京地区正常人群中的应用[J]. 中国心理卫生杂志, 2010,24(12):926.
[22] Zung WW . A self-rating depression scale[J]. Arch Gen Psychiatry, 1965,12:63-70.
[23] Papagianni A, Kalovoulos M, Kirmizis D , et al. Carotid atherosclerosis is associated with inflammation and endothelial cell adhesion molecules in chronic haemodialysis patients[J]. Nephrol Dial Transplant, 2003,18(1):113-119.
[24] Bartens W, Nauck M, Schollmeyer P , et al. Elevated lipoprotein(a)and fibrinogen levels [corrected] increase the cardiovascular risk in continuous ambulatory peritoneal dialysis patients[J]. Perit Dial Int, 1996,16(1):27-33.
[25] Irish A . Cardiovascular disease, fibrinogen and theacute phase response: associations with lipids and blood pressure in patients with chronic renal disease[J]. Atherosclerosis, 1998,137(1):133-139.
[26] Pi HC, Xu YF, Xu R , et al. Cognitive impairment and structural neuroimaging abnormalities among patients with chronic kidney disease [J]. Kidney Blood Press Res, 2016,41(6):986-996.
Outlines

/